Result of AGM

RNS Number : 5852N
JPMorgan China Growth & Income PLC
01 February 2021
 

 

JPMORGAN CHINA GROWTH & INCOME PLC

 

RESULTS OF ANNUAL GENERAL MEETING

 

Legal Entity Identifier: 549300S8M91P5FYONY25

 

Following the Annual General Meeting of the Company, which was held earlier today, the Board is pleased to announce that all the Ordinary Resolutions put to shareholders were passed.  In addition, the following items of Special Business were also passed which:

 

i.)  will allow the Company to allot shares up to an aggregate nominal amount of £1,849,829 representing approximately 10% of the Company's issued share capital ;

 

ii.)  will allow the disapplication of pre-emption rights on the allotment of shares;

 

iii.)  will allow the Company to allot further new Ordinary shares up to an aggregate nominal amount of £1,849,829 representing approximately 10%  of the Company's issued share capital;

 

iv.)  will allow the disapplication of pre-emption rights on the further allotment of shares;

 

v.)  will allow the Company to make market purchases of up to 11,091,578 Ordinary shares representing 14.99% of the Company's issued share capital;

 

vi.)  approve the Company's dividend policy to continue to pay four quarterly interim dividends during the year; and

 

vii.)  adopt new Articles of Association of the Company.

The full text of the resolutions can be found in the notice of meeting contained in the Annual Report and Financial Statements which is available for viewing at the National Storage Mechanism which can be located at https://data.fca.org.uk/#/nsm/nationalstoragemechanism  and from the Company's website   www.jpmchinagrowthandincome.co.uk .

The full results of the poll conducted at today's meeting will shortly be available on the Company's website.

 

1st February 2021

 

 

For further information, please contact:

 

Lucy Dina

For and on behalf of

JPMorgan Funds Limited, Secretary

020 7742 4000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUAAORAKUURAR
UK 100

Latest directors dealings